MICRONUTRIENT LEVELS IN HIV-1-INFECTED CHILDREN

被引:56
|
作者
PERIQUET, BA
JAMMES, NM
LAMBERT, WE
TRICOIRE, J
MOUSSA, MM
GARCIA, J
GHISOLFI, J
THOUVENOT, JP
机构
[1] STATE UNIV GHENT,TOXICOL LAB,GHENT,BELGIUM
[2] PURPAN HOSP,DEPT PAEDIAT MED,TOULOUSE,FRANCE
[3] PURPAN HOSP,STUDY GRP PAEDIAT NUTR,TOULOUSE,FRANCE
关键词
HIV-1-INFECTED CHILDREN; AIDS; NUTRITIONAL STATUS MARKERS; MICRONUTRIENTS; IMMUNITY;
D O I
10.1097/00002030-199508000-00009
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: Micronutrients (zinc, copper, selenium, vitamin A, E, and carotenoids) are essential for the integrity of host defences. This study was designed to determine the prevalence of abnormalities of the micronutrient levels in HIV-1-seropositive children. Design: Prospective study. Setting: The study was performed on HIV-l-infected children at the Paediatric Haematology and Oncology Unit of Toulouse Hospital, France. Patients: Twenty-one children, suffering from HIV-1 infection and 21 control subjects of similar age (2-9 years) were included in the study. In the HIV-1-infected children, two subgroups were considered according to stage (non-AIDS or AIDS), based on the Centers for Disease Control and Prevention 1987 criteria. Results: The first statistically significant deficiencies occurred at non-AIDS stage and were confirmed at AIDS stage: P<0.05 for lycopene, retinol, tocopherol and P<0.001 for transthyretin and serum albumin. Levels of copper (40%) and long-chain polyunsaturated fatty acids (21%) were higher in the non-AIDS group than the controls. Conclusion: Biological impairing of the micronutrient levels was observed in the non-AIDS stage without clinical sign. This information is useful in delineating eventual and well considered nutritional intervention strategies that may improve the clinical status of HIV-1-infected children and perhaps alter the course of their disease.
引用
收藏
页码:887 / 893
页数:7
相关论文
共 50 条
  • [1] Micronutrient profiles in HIV-1-Infected heterosexual adults
    Skurnick, JH
    Bogden, JD
    Baker, H
    Kemp, FW
    Sheffet, A
    Quattrone, G
    Louria, DB
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1996, 12 (01) : 75 - 83
  • [2] MICRONUTRIENT NUTRITION IN HIV-1-INFECTED HETEROSEXUAL ADULTS
    BOGDEN, JD
    SKURNICK, JH
    BAKER, H
    KEMP, FW
    SHEFFET, A
    QUATTRON, G
    LOURIA, DB
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1995, : 216 - 216
  • [3] BLOOD HISTAMINE LEVELS IN HIV-1-INFECTED INFANTS AND CHILDREN
    BURTIN, C
    BLANCHE, S
    GALOPPIN, L
    MERVAL, R
    GRISCELLI, C
    SCHEINMANN, P
    INTERNATIONAL ARCHIVES OF ALLERGY AND APPLIED IMMUNOLOGY, 1990, 91 (02): : 142 - 144
  • [4] Nevirapine use in HIV-1-infected children
    Verweel, G
    Sharland, M
    Lyall, H
    Novelli, V
    Gibb, DM
    Dumont, G
    Ball, C
    Wilkins, E
    Walters, S
    Tudor-Williams, G
    AIDS, 2003, 17 (11) : 1639 - 1647
  • [5] Vaccination recommendations for HIV-1-infected children
    Papaevangelou, V
    Borkowsky, W
    CLINICAL IMMUNOTHERAPEUTICS, 1996, 5 (01): : 5 - 12
  • [6] The pharmacokinetics of nelfinavir in HIV-1-infected children
    van Heeswijk, RPG
    Scherpbier, HJ
    de Koning, LA
    Heymans, HSA
    Lange, JMA
    Beijnen, JH
    Hoetelmans, RMW
    THERAPEUTIC DRUG MONITORING, 2002, 24 (04) : 487 - 491
  • [7] Pharmacokinetics of antiretroviral therapy in HIV-1-infected children
    Fraaij, PLA
    van Kampen, JJA
    Burger, DM
    de Groot, R
    CLINICAL PHARMACOKINETICS, 2005, 44 (09) : 935 - 956
  • [8] PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY IN HIV-1-INFECTED CHILDREN
    BERGER, JR
    SCOTT, G
    ALBRECHT, J
    BELMAN, AL
    TORNATORE, C
    MAJOR, EO
    AIDS, 1992, 6 (08) : 837 - 841
  • [9] Population pharmacokinetics of nelfinavir in hiv-1-infected children
    Crommentuyn, KML
    Huitema, ADR
    van Heeswijk, RPG
    Mathôt, RAA
    Scherpbier, HJ
    Kuijpers, TW
    Beijnen, JH
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 57 (03) : 355 - 356
  • [10] Pharmacokinetics of Antiretroviral Therapy in HIV-1-Infected Children
    Pieter L. A. Fraaij
    Jeroen J. A. van Kampen
    David M. Burger
    Ronald de Groot
    Clinical Pharmacokinetics, 2005, 44 : 935 - 956